Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Pelvic Mass

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44359   clinical trials with a EudraCT protocol, of which   7384   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    38 result(s) found for: Pelvic Mass. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2018-001098-26 Sponsor Protocol Number: MK-7264-034 Start Date*: 2018-09-21
    Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
    Full Title: A Phase 2a, Proof of Concept, Randomized, Double-blind, Placebo-controlled Clinical Trial, to Evaluate the Efficacy and Safety of MK-7264 in Women with Moderate to Severe Endometriosis-related Pain
    Medical condition: Moderate to severe Endometriosis-related pain (ERP)
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004872 10014788 Endometriosis related pain LLT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed) PL (Completed)
    Trial results: View results
    EudraCT Number: 2015-004326-34 Sponsor Protocol Number: MK8342B-060 Start Date*: 2016-02-12
    Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
    Full Title: A Phase 3 Randomized, Double-blind, Placebo-Controlled Trial to Study the Efficacy and Safety of MK-8342B (ENG-E2 vaginal ring) in Women with Moderate to Severe Primary Dysmenorrhea.
    Medical condition: Moderate to severe primary dysmenorrhea
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004872 10062851 Primary dysmenorrhea LLT
    19.0 100000004872 10013934 Dysmenorrhea LLT
    Population Age: Adolescents, Under 18, Adults Gender: Female
    Trial protocol: SE (Completed) PL (Prematurely Ended) IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2013-005494-53 Sponsor Protocol Number: Start Date*: 2014-10-16
    Sponsor Name:Norfolk and Norwich University Hospitals NHS Foundation Trust
    Full Title: A Study of the Histopathological Changes within Ectopic Endometrial Tissue, in Subjects with Known Pelvic Endometriosis Following Treatment with Ulipristal Acetate, a Selective Progesterone Recepto...
    Medical condition: Endometriosis
    Disease: Version SOC Term Classification Code Term Level
    17.0 10042613 - Surgical and medical procedures 10057902 Endometriosis ablation PT
    17.0 10038604 - Reproductive system and breast disorders 10014785 Endometriosis of pelvic peritoneum LLT
    17.0 10038604 - Reproductive system and breast disorders 10014788 Endometriosis related pain LLT
    17.0 10042613 - Surgical and medical procedures 10014779 Endometriosis in pelvis, excision LLT
    17.0 10038604 - Reproductive system and breast disorders 10014778 Endometriosis PT
    Population Age: Adults Gender: Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2015-004325-14 Sponsor Protocol Number: MK8342B-059 Start Date*: 2016-04-15
    Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.,Inc.
    Full Title: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial to Study the Efficacy and Safety of MK-8342B (ENG-E2 Vaginal Ring) in Women with Moderate to Severe Primary Dysmenorrhea (with Optional ...
    Medical condition: Treatment of primary dysmenorrhea
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004872 10062851 Primary dysmenorrhea LLT
    18.1 100000004872 10013934 Dysmenorrhea LLT
    Population Age: Adolescents, Under 18, Adults Gender: Female
    Trial protocol: DE (Completed) FI (Completed)
    Trial results: View results
    EudraCT Number: 2015-001199-23 Sponsor Protocol Number: ICR-CTSU/2014/10048 Start Date*: 2016-10-11
    Sponsor Name:The Institute of Cancer Research
    Full Title: InPACT - International Penile Advanced Cancer Trial (International Rare Cancer Initiative)
    Medical condition: Locally advanced squamous carcinoma of the penis
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10034299 Penile cancer PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2007-006474-28 Sponsor Protocol Number: NBI-56418-0703 Start Date*: 2008-05-14
    Sponsor Name:Neurocrine Biosciences, INC
    Full Title: A Phase II, Randomized, Double-Blind, Placebo- and Active-Controlled Study to Assess the Efficacy and Safety of NBI-56418 in Subjects with Endometriosis
    Medical condition: Endometriosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10014778 Endometriosis LLT
    Population Age: Adults Gender: Female
    Trial protocol: HU (Completed) PL (Completed) BG (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-004043-21 Sponsor Protocol Number: 16-OBE2109-016 Start Date*: 2018-10-17
    Sponsor Name:ObsEva SA
    Full Title: An exploratory, single centre, open label, pilot study investigating the efficacy and safety of OBE2109 200 mg daily For 12 weeks followed by 100 mg daily for 12 weeks in rectovaginal endometriosis.
    Medical condition: Rectovaginal endometriosis
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: FR (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-004429-45 Sponsor Protocol Number: CHORUS Start Date*: 2008-02-04
    Sponsor Name:Medical Research Council
    Full Title: A randomised trial to determine the impact of timing of surgery and chemotherapy in newly diagnosed patients with advanced epithelial ovarian, primary peritoneal or fallopian tube carcinoma
    Medical condition: Women with newly diagnosed, suspected, advanced (compatible with FIGO stage III/IV) ovarian, primary peritoneal or fallopian tube cancer who fulfil other entry criteria, with clinical and/or imagin...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10033131 Ovarian carcinoma LLT
    9.1 10052171 Peritoneal carcinoma LLT
    9.1 10016180 Fallopian tube cancer LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2012-002449-40 Sponsor Protocol Number: P057-00 Start Date*: 2012-10-12
    Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
    Full Title: A multicenter, randomized, partially blinded, placebo-controlled clinical trial to evaluate the effect on primary dysmenorrheal of vaginal rings with an average daily release of 700 μg nomegestrol...
    Medical condition: This study will investigate the use of 4 doses of combined contraceptives (a progestin with an estrogen) in a vaginal ring dosage form for the treatment of dysmenorrhea (menstrual cramping pain). A...
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) NO (Completed) NL (Completed) BE (Completed) SE (Completed) PL (Completed) DK (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2020-000090-25 Sponsor Protocol Number: TUC3PII-01 Start Date*: 2021-06-23
    Sponsor Name:TiumBio Co., Ltd.
    Full Title: A Phase IIa, Multicenter, Randomized, Double-Blind, Parallel- Group, Placebo-Controlled, Proof of Concept Study to Evaluate the Efficacy and Safety of Orally Administered TU2670 in Subjects with Mo...
    Medical condition: Moderate to Severe Endometriosis-Associated Pain
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004872 10014788 Endometriosis related pain LLT
    Population Age: Adults Gender: Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2020-005546-42 Sponsor Protocol Number: MELISA Start Date*: 2021-06-21
    Sponsor Name:Fundacio Clinic per a la Recerca Biomedica
    Full Title: Sentinel lymph node assessment in ovarian cancer. Lymphatic mapping with two tracers and intraoperative lymphoscintigraphy.
    Medical condition: Sentinel lymph node in ovarian cancer
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004848 10072873 Sentinel lymph node mapping LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-004042-14 Sponsor Protocol Number: 16-OBE2109-015 Start Date*: 2018-04-23
    Sponsor Name:ObsEva SA
    Full Title: An exploratory single centre, open label, pilot study investigating the efficacy and safety of OBE2109 200 mg daily for 12 weeks followed by 100 mg daily for 12 weeks in uterine adenomyosis.
    Medical condition: Uterine adenomyosis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004872 10058953 Adenomyosis uteri LLT
    Population Age: Adults Gender: Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2020-003663-26 Sponsor Protocol Number: UC-GTG-2006 Start Date*: 2021-11-19
    Sponsor Name:UNICANCER
    Full Title: A double-blind randomised phase III trial evaluating the efficacy of ADT +/- darolutamide in de novo metastatic prostate cancer patients with vulnerable functional ability and not elected for docet...
    Medical condition: Adenocarcinoma of the prostate
    Disease: Version SOC Term Classification Code Term Level
    21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10036909 Prostate cancer metastatic PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: FR (Trial now transitioned) IE (Trial now transitioned) BE (Trial now transitioned) ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-019411-37 Sponsor Protocol Number: FE999906CS11 Start Date*: 2010-08-30
    Sponsor Name:FERRING Arzneimittel GmbH
    Full Title: A Prospective, Open Label, Randomised, Parallel Group Trial Comparing the Effects of Highly Purified Menotrophin and Recombinant Follicle Stimulating Hormone (rFSH, Follitropin alpha) Administered ...
    Medical condition: Controlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies
    Disease: Version SOC Term Classification Code Term Level
    14.0 10038604 - Reproductive system and breast disorders 10021926 Infertility PT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-003466-34 Sponsor Protocol Number: M06OVH Start Date*: 2006-12-14
    Sponsor Name:NKI-AVL
    Full Title: Phase III randomised clinical trial for stage III ovarian carcinoma randomising between secondary debulking surgery with or without hyperthermic intraperitoneal chemotherapy (OVHIPEC-I)
    Medical condition: ovarian carcinoma or peritoneal cancer (PPSC) or fallopian tube carcinoma FIGO Stage III
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-001719-39 Sponsor Protocol Number: INN-CB-002 Start Date*: 2008-07-23
    Sponsor Name:Innocoll Technologies
    Full Title: A Phase II, Single Dose, Blinded, Prospective Study to Investigate the Efficacy and Safety of the CollaRx® Bupivacaine Implant in Women following Abdominal Hysterectomy or other Nonlaparoscopic Ben...
    Medical condition: To investigate the efficacy and safety of the CollaRx Bupivacaine Implant in women following abdominal hysterectomy or other nonlaparoscopic benign gynecological procedure
    Disease: Version SOC Term Classification Code Term Level
    9.1 10044080 Total abdominal hysterectomy LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2004-001307-35 Sponsor Protocol Number: FE999906 CS004 Start Date*: 2005-12-22
    Sponsor Name:Ferring Arzneimittel GmbH
    Full Title: A prospective, open label, randomised, parallel group, comparative pilot study to study the efficacy and safety of highly purified Menotrophin versus recombinant FSH (Follitropin alfa) administered...
    Medical condition: sub fertility
    Disease: Version SOC Term Classification Code Term Level
    7.1 10042391 LLT
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2004-003829-28 Sponsor Protocol Number: TAK-013/EC204 Start Date*: 2004-12-22
    Sponsor Name:Takeda Europe R&D Centre Ltd
    Full Title: An open-label investigation into the tolerability and pharmacokinetic / pharmacodynamic effects of sufugolix (TAK-013), at a dosage of 100mg twice-daily, during six months treatment of pre-menopaus...
    Medical condition: symptomatic endometriosis
    Disease: Version SOC Term Classification Code Term Level
    7 10014778 LLT
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed) DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2008-004861-25 Sponsor Protocol Number: A4091019 Start Date*: 2009-03-05
    Sponsor Name:Pfizer Ltd., Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
    Full Title: A PHASE 2, 16 WEEK, MULTICENTER, RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED, PARALLEL GROUP PROOF-OF-CONCEPT STUDY EVALUATING THE EFFICACY AND SAFETY OF TANEZUMAB FOR THE TREATMENT OF PAIN ASSOCIA...
    Medical condition: Chronic Abacterial Prostatitis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10009109 Chronic prostatitis LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: SE (Completed) FR (Completed)
    Trial results: View results
    EudraCT Number: 2004-003820-37 Sponsor Protocol Number: IGIT-008 Start Date*: 2005-02-10
    Sponsor Name:Bracco Imaging Spa
    Full Title: A multicentre study to evaluate the Contibution of SonoVue® and CnTI technology (Contrast Tuned Imaging) to a correct classification of Adnexal Masses as benign or malignant
    Medical condition: COMPLEX ADNEXAL MASS IN PELVIS
    Disease: Version SOC Term Classification Code Term Level
    10029104 SOC
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: SE (Completed) BE (Completed) IT (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu Sep 11 20:49:00 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA